Literature DB >> 12615638

Alzheimer's disease with spastic paraparesis and 'cotton wool' plaques: two pedigrees with PS-1 exon 9 deletions.

William S Brooks1, John B J Kwok, Jillian J Kril, G Anthony Broe, Peter C Blumbergs, Anthony E Tannenberg, Phillipa J Lamont, Philippa Hedges, Peter R Schofield.   

Abstract

Several pedigrees have recently been reported in which dominantly inherited familial Alzheimer's disease is associated in some family members with spastic paraparesis and non-neuritic 'cotton wool' plaques. Here we report clinical, genetic and neuropathological findings in two further large pedigrees in which this combination of phenotypes is associated with a deletion of exon 9 of the presenilin-1 (PS-1) gene caused by mutations at the splice acceptor site. In both pedigrees, individuals with paraparesis at presentation had a later than average age at onset of symptoms. In addition, one subject with paraparesis had a much less prominent dementia syndrome than his dementia-affected siblings. As PS-1 mutations are almost always associated with a particularly aggressive form of presenile dementia, these findings suggest the existence of a protective or delaying factor in individuals with spastic paraparesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12615638     DOI: 10.1093/brain/awg084

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  16 in total

1.  Impairments in fast axonal transport and motor neuron deficits in transgenic mice expressing familial Alzheimer's disease-linked mutant presenilin 1.

Authors:  Orly Lazarov; Gerardo A Morfini; Gustavo Pigino; Archana Gadadhar; Xiangjun Chen; John Robinson; Hanson Ho; Scott T Brady; Sangram S Sisodia
Journal:  J Neurosci       Date:  2007-06-27       Impact factor: 6.167

2.  Early onset familial Alzheimer Disease with spastic paraparesis, dysarthria, and seizures and N135S mutation in PSEN1.

Authors:  Leslie A Rudzinski; Rita M Fletcher; Dennis W Dickson; Richard Crook; Michael L Hutton; Jennifer Adamson; Neill R Graff-Radford
Journal:  Alzheimer Dis Assoc Disord       Date:  2008 Jul-Sep       Impact factor: 2.703

3.  Difficult case of a rare form of familial Alzheimer's disease with PSEN1 P117L mutation.

Authors:  Ana Luísa Rocha; Andreia Costa; Maria Carolina Garrett; Joana Meireles
Journal:  BMJ Case Rep       Date:  2018-12-13

Review 4.  Presenilins function in ER calcium leak and Alzheimer's disease pathogenesis.

Authors:  Charlene Supnet; Ilya Bezprozvanny
Journal:  Cell Calcium       Date:  2011-06-12       Impact factor: 6.817

Review 5.  Alzheimer disease.

Authors:  Rudy J Castellani; Raj K Rolston; Mark A Smith
Journal:  Dis Mon       Date:  2010-09       Impact factor: 3.800

6.  Familial Alzheimer's disease mutations in presenilins: effects on endoplasmic reticulum calcium homeostasis and correlation with clinical phenotypes.

Authors:  Omar Nelson; Charlene Supnet; Huarui Liu; Ilya Bezprozvanny
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

7.  Neuropathology and biochemistry of early onset familial Alzheimer's disease caused by presenilin-1 missense mutation Thr116Asn.

Authors:  Stanislav Sutovsky; Tomas Smolek; Peter Turcani; Robert Petrovic; Petra Brandoburova; Santosh Jadhav; Petr Novak; Johannes Attems; Norbert Zilka
Journal:  J Neural Transm (Vienna)       Date:  2018-02-05       Impact factor: 3.575

Review 8.  Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene.

Authors:  A J Larner; M Doran
Journal:  J Neurol       Date:  2005-11-04       Impact factor: 6.682

Review 9.  Antioxidant therapies for Alzheimer's disease.

Authors:  Ye Feng; Xiaochuan Wang
Journal:  Oxid Med Cell Longev       Date:  2012-07-25       Impact factor: 6.543

10.  Variability in the type and layer distribution of cortical Aβ pathology in familial Alzheimer's disease.

Authors:  Nanet Willumsen; Teresa Poole; Jennifer M Nicholas; Nick C Fox; Natalie S Ryan; Tammaryn Lashley
Journal:  Brain Pathol       Date:  2021-07-28       Impact factor: 7.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.